Cargando…

Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial

BACKGROUND: Remimazolam is a novel, ultrashort-acting benzodiazepine that can be antagonized by flumazenil. This study aimed to determine whether remimazolam-based anesthesia with flumazenil provides a more rapid emergence than propofol-based anesthesia in older patients undergoing spinal surgery. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyota, Yukari, Kondo, Takashi, Oshita, Kyoko, Haraki, Toshiaki, Narasaki, Soshi, Kido, Kenshiro, Kamiya, Satoshi, Nakamura, Ryuji, Saeki, Noboru, Horikawa, Yousuke T., Tsutsumi, Yasuo M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659722/
https://www.ncbi.nlm.nih.gov/pubmed/37986333
http://dx.doi.org/10.1097/MD.0000000000036081
_version_ 1785148372802338816
author Toyota, Yukari
Kondo, Takashi
Oshita, Kyoko
Haraki, Toshiaki
Narasaki, Soshi
Kido, Kenshiro
Kamiya, Satoshi
Nakamura, Ryuji
Saeki, Noboru
Horikawa, Yousuke T.
Tsutsumi, Yasuo M.
author_facet Toyota, Yukari
Kondo, Takashi
Oshita, Kyoko
Haraki, Toshiaki
Narasaki, Soshi
Kido, Kenshiro
Kamiya, Satoshi
Nakamura, Ryuji
Saeki, Noboru
Horikawa, Yousuke T.
Tsutsumi, Yasuo M.
author_sort Toyota, Yukari
collection PubMed
description BACKGROUND: Remimazolam is a novel, ultrashort-acting benzodiazepine that can be antagonized by flumazenil. This study aimed to determine whether remimazolam-based anesthesia with flumazenil provides a more rapid emergence than propofol-based anesthesia in older patients undergoing spinal surgery. METHODS: This was a prospective, single-blind, randomized controlled trial. Forty-four patients > 75 years old who had undergone spinal surgery were enrolled in this study. They were randomly assigned to the remimazolam or propofol group (1:1) using a computer randomization system stratified by age and body weight. For anesthesia induction and maintenance, remifentanil was administered at a defined dose in both groups, and remimazolam or propofol was adjusted to maintain the bispectral index or state entropy monitoring within 40–60. All anesthetics were discontinued simultaneously after the postoperative X-ray and 0.5 mg flumazenil was administered to the remimazolam group. The primary outcome was extubation time after discontinuing anesthesia, and the secondary outcomes were time to eye opening, obeying commands, and achieving a white fast-track score (WFTS) of 12. RESULTS: Thirty-nine patients were finally analyzed: remimazolam group (n = 20), propofol group (n = 19). There were no significant differences in intraoperative variables, such as operative time, anesthesia time, and patient background, between the 2 groups. Extubation times were significantly shorter in the remimazolam group than in the propofol group (4 vs 8 minutes, P < .001). The time to eye opening, obeying commands, and achieving a WFTS of 12 were significantly shorter in the remimazolam group (P < .001, for all comparisons). CONCLUSION: Remimazolam-based anesthesia with flumazenil resulted in a faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery.
format Online
Article
Text
id pubmed-10659722
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106597222023-11-17 Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial Toyota, Yukari Kondo, Takashi Oshita, Kyoko Haraki, Toshiaki Narasaki, Soshi Kido, Kenshiro Kamiya, Satoshi Nakamura, Ryuji Saeki, Noboru Horikawa, Yousuke T. Tsutsumi, Yasuo M. Medicine (Baltimore) 3300 BACKGROUND: Remimazolam is a novel, ultrashort-acting benzodiazepine that can be antagonized by flumazenil. This study aimed to determine whether remimazolam-based anesthesia with flumazenil provides a more rapid emergence than propofol-based anesthesia in older patients undergoing spinal surgery. METHODS: This was a prospective, single-blind, randomized controlled trial. Forty-four patients > 75 years old who had undergone spinal surgery were enrolled in this study. They were randomly assigned to the remimazolam or propofol group (1:1) using a computer randomization system stratified by age and body weight. For anesthesia induction and maintenance, remifentanil was administered at a defined dose in both groups, and remimazolam or propofol was adjusted to maintain the bispectral index or state entropy monitoring within 40–60. All anesthetics were discontinued simultaneously after the postoperative X-ray and 0.5 mg flumazenil was administered to the remimazolam group. The primary outcome was extubation time after discontinuing anesthesia, and the secondary outcomes were time to eye opening, obeying commands, and achieving a white fast-track score (WFTS) of 12. RESULTS: Thirty-nine patients were finally analyzed: remimazolam group (n = 20), propofol group (n = 19). There were no significant differences in intraoperative variables, such as operative time, anesthesia time, and patient background, between the 2 groups. Extubation times were significantly shorter in the remimazolam group than in the propofol group (4 vs 8 minutes, P < .001). The time to eye opening, obeying commands, and achieving a WFTS of 12 were significantly shorter in the remimazolam group (P < .001, for all comparisons). CONCLUSION: Remimazolam-based anesthesia with flumazenil resulted in a faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery. Lippincott Williams & Wilkins 2023-11-17 /pmc/articles/PMC10659722/ /pubmed/37986333 http://dx.doi.org/10.1097/MD.0000000000036081 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 3300
Toyota, Yukari
Kondo, Takashi
Oshita, Kyoko
Haraki, Toshiaki
Narasaki, Soshi
Kido, Kenshiro
Kamiya, Satoshi
Nakamura, Ryuji
Saeki, Noboru
Horikawa, Yousuke T.
Tsutsumi, Yasuo M.
Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial
title Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial
title_full Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial
title_fullStr Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial
title_full_unstemmed Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial
title_short Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial
title_sort remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: a randomized controlled trial
topic 3300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659722/
https://www.ncbi.nlm.nih.gov/pubmed/37986333
http://dx.doi.org/10.1097/MD.0000000000036081
work_keys_str_mv AT toyotayukari remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial
AT kondotakashi remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial
AT oshitakyoko remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial
AT harakitoshiaki remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial
AT narasakisoshi remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial
AT kidokenshiro remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial
AT kamiyasatoshi remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial
AT nakamuraryuji remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial
AT saekinoboru remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial
AT horikawayousuket remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial
AT tsutsumiyasuom remimazolambasedanesthesiawithflumazenilallowsfasteremergencethanpropofolbasedanesthesiainolderpatientsundergoingspinalsurgeryarandomizedcontrolledtrial